Skip to main content
Atrás
Watch Compare

Arcturus Therapeutics Holdings Inc.

Calidad de datos: 100%
ARCT
Nasdaq Manufacturing Chemicals
$8.28
▼ $0.22 (-2.59%)
Cap. Mercado: 235.34 M
Precio
$8.28
Cap. Mercado
235.34 M
Rango del Día
$8.20 — $8.46
Rango de 52 Semanas
$5.85 — $24.17
Volumen
220,819
Apertura $8.46
Promedio 50D / 200D
$7.40
11.93% above
Promedio 50D / 200D
$11.47
27.80% below

Quick Summary

Puntos Clave

Revenue grew 60.51% annually over 5 years — strong growth
Negative free cash flow of -74.50 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 106.65%
Capital efficient — spends only 0.28% of revenue on capex

Crecimiento

Revenue Growth (5Y)
60.51%
Above sector avg (9.35%)
Revenue (1Y)-46.14%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-28.88%
Above sector avg (-51.02%)
ROIC-23.47%
Net Margin-80.19%
Op. Margin-92.96%

Seguridad

Debt / Equity
N/A
Current Ratio7.86
Interest CoverageN/A

Valoración

PE (TTM)
-3.58
Below sector avg (-1.98)
P/B Ratio1.05
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -3.6 -2.0
P/B 1.1 5.1
ROE % -28.9 -51.0
Net Margin % -80.2 -150.2
Rev Growth 5Y % 60.5 9.3
D/E — 0.3

ETFs Holding This Stock

NXTE logo NXTE AXS Green Alpha ETF
0.23% weight
LABU logo LABU Direxion Daily S&P Biotech Bull 3X ETF
0.10% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.04% weight
EES logo EES WisdomTree U.S. SmallCap Fund
0.03% weight
AVUS logo AVUS Avantis U.S. Equity ETF
0.00% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -46.14% Revenue Growth (3Y) -29.87%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 60.51% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 82.03 M Net Income (TTM) -65.78 M
ROE -28.88% ROA -22.24%
Gross Margin N/A Operating Margin -92.96%
Net Margin -80.19% Free Cash Flow (TTM) -74.50 M
ROIC -23.47% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 7.86
Interest Coverage N/A Asset Turnover 0.28
Working Capital 217.50 M Tangible Book Value 224.56 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3.58 Forward P/E N/A
P/B Ratio 1.05 P/S Ratio 2.87
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -31.66%
Market Cap 235.34 M Enterprise Value 54.98 M
Per Share
EPS (Diluted TTM) -2.40 Revenue / Share 2.89
FCF / Share -2.62 OCF / Share -2.61
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.28% FCF Conversion 113.25%
SBC-Adj. FCF -102.59 M Growth Momentum -106.65

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 82.03 M 152.31 M 166.80 M 206.00 M 12.36 M
Net Income -65.78 M -80.94 M -29.73 M 9.35 M -203.67 M
EPS (Diluted) -2.40 -3.00 -1.12 0.35 —
Gross Profit — — — — —
Operating Income -76.26 M -95.67 M -78.21 M 12.18 M -202.85 M
EBITDA — — — — —
R&D Expenses 112.21 M 195.16 M 192.13 M 147.75 M 173.76 M
SG&A Expenses — — — — —
D&A 3.03 M 3.54 M 2.96 M 1.53 M 1.19 M
Interest Expense — — — — —
Income Tax -4,000.0 -4,000.0 1.84 M 1.30 M —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 271.15 M 344.07 M 429.40 M 450.39 M 392.81 M
Total Liabilities 57.16 M 103.09 M 150.89 M 180.08 M 164.60 M
Shareholders' Equity 213.99 M 240.98 M 278.51 M 270.31 M 228.21 M
Total Debt — — — 40.63 M 15.30 M
Cash & Equivalents 230.91 M 237.03 M 292.01 M 391.88 M 370.49 M
Current Assets 241.45 M 305.98 M 386.59 M 403.33 M 378.96 M
Current Liabilities 36.38 M 65.49 M 81.99 M 126.98 M 99.54 M